Royalty Pharma plcRPRXNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank59
5Y CAGR-19.8%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-19.8%/yr
Long-term compound
Percentile
P59
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.08% |
| Q3 2025 | 5.29% |
| Q2 2025 | 1.83% |
| Q1 2025 | -4.28% |
| Q4 2024 | 5.13% |
| Q3 2024 | 5.10% |
| Q2 2024 | -5.41% |
| Q1 2024 | -4.71% |
| Q4 2023 | 11.14% |
| Q3 2023 | -0.35% |
| Q2 2023 | -21.31% |
| Q1 2023 | 20.90% |
| Q4 2022 | -1.35% |
| Q3 2022 | 7.00% |
| Q2 2022 | -4.64% |
| Q1 2022 | -2.37% |
| Q4 2021 | -1.72% |
| Q3 2021 | 5.55% |
| Q2 2021 | -3.15% |
| Q1 2021 | 0.15% |
| Q4 2020 | 6.27% |
| Q3 2020 | 5.38% |
| Q2 2020 | 2.01% |
| Q1 2020 | 9.49% |
| Q4 2019 | -1.46% |
| Q3 2019 | 1.46% |
| Q2 2019 | 5.23% |
| Q1 2019 | 0.00% |